Mphasha, M. H.
Mothiba, T. M.
Skaal, L.
Article History
Received: 23 May 2022
Accepted: 17 October 2022
First Online: 23 December 2022
Declarations
:
: Turfloop Research Ethical Committee (TREC) approved this study with clearance certificate number <i>TREC/35/2019: PG</i>. Permission to conduct the study was obtained from Limpopo Department of Health with reference <i>Ref: LP 201903–007</i>. All methods were performed in accordance with the Declaration of Helsinki. All respondents voluntarily gave and signed written informed consent for participation in the study. Participants were alerted about their privileges to withdraw from the study at any stage without punishment, and that their withdrawal would not affect diabetes treatment received from the facilities. None of the respondents withdrew from the study. Privacy of the respondents was maintained by interviewing patients in private consulting rooms of the clinics. Confidentiality was maintained by not capturing the real names of participants.
: Not applicable.
: The authors declare no competing interests.